Patents by Inventor Thomas A. Hendrickson

Thomas A. Hendrickson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9659624
    Abstract: In some aspects, the disclosure is directed to methods and systems for sense reference generation. A first array and a second array of MTJ based cells are configured as a magnetoresistive random access memory block. The first array is matched to the second array, the first array and the second array each including rows of MTJ based cells for storing data bits. Responsive to a first row of MTJ based cells in the first array being selected for at least a first stored data bit to be read, a reference row of MTJ based cells in the second array is connected to at least a first comparator of a plurality of comparators via reference lines, to provide sense reference for determining a value of the first stored data bit. The reference lines are shorted together prior to connecting to a first input of the first comparator.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: May 23, 2017
    Assignee: Avago Technologies General IP (Singapore) Pte. Ltd.
    Inventors: Nick Thomas Hendrickson, Myron Buer, Ron Daniel Isliefson
  • Patent number: 8563549
    Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: October 22, 2013
    Assignee: Novartis AG
    Inventors: Matthew Burger, Zhi-Jie Ni, Sabina Pecchi, Gordana Ataliah, Sarah Bartulis, Kelly Frazier, Aaron Smith, Joelle Verhagen, Yanchen Zhang, Allan Wagman, Simon Ng, Keith Pfister, Daniel J. Poon, Alicia Louie, Teresa Pick, Paul Barsanti, Edwin Iwanowicz, Wendy Fantl, Thomas Hendrickson, Mark Knapp, Hanne Meritt, Charles Voliva, Marion Wiesmann, Xiahua Xin
  • Patent number: 8516181
    Abstract: A memory device having a pipeline monitor and control block to issue a memory pipeline with process flows specific to NVM operation to optimize system performance.
    Type: Grant
    Filed: March 31, 2009
    Date of Patent: August 20, 2013
    Assignee: Micron Technology, Inc.
    Inventor: Nicholas Thomas Hendrickson
  • Publication number: 20120225859
    Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.
    Type: Application
    Filed: May 14, 2012
    Publication date: September 6, 2012
    Applicant: NOVARTIS AG
    Inventors: Matthew BURGER, Zhi-Jie NI, Sabina PECCHI, Gordana ATALLAH, Sarah BARTULIS, Kelly FRAZIER, Aaron SMITH, Joelle VERHAGEN, Yanchen ZHANG, Allan WAGMAN, Simon NG, Keith PFISTER, Daniel POON, Alicia LOUIE, Teresa PICK, Paul BARSANTI, Edwin IWANOWICZ, Wendy FANTL, Thomas HENDRICKSON, Mark KNAPP, Hanne MERRITT, Charles VOLIVA, Marion WIESMANN, Xiaohua XIN
  • Patent number: 8217035
    Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: July 10, 2012
    Assignee: Novartis AG
    Inventors: Matthew Burger, Zhi-Jie Ni, Sabina Pecchi, Gordana Atallah, Sarah Bartulis, Kelly Frazier, Aaron Smith, Joelle Verhagen, Yanchen Zhang, Allan Wagman, Simon Ng, Keith Pfister, Daniel Poon, Alicia Louie, Teresa Pick, Paul Barsanti, Edwin Iwanowicz, Wendy Fantl, Thomas Hendrickson, Mark Knapp, Hanne Merritt, Charles Voliva, Marion Wiesmann, Xiaohua Xin
  • Publication number: 20110083701
    Abstract: A method for conveying a chemical solution containing a phosphonic acid as an iron dissolving agent through the quaternary annulus chambers in forward combustion cans of a gas turbine to dissolve the iron oxide deposits and thereby facilitate cleaning of the internal fuel pathways. The method uses a cleaning flange attached to the quaternary fuel flange that has a flow directing baffle that enters the quaternary fuel orifice and directs the flow of cleaning solution in one direction in the quaternary annulus chamber.
    Type: Application
    Filed: October 9, 2009
    Publication date: April 14, 2011
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Mel Joseph Esmacher, James Lee Standard, Roy Nelson Mckean, Martin John Spalding, Eric Thomas Hendrickson
  • Publication number: 20100249126
    Abstract: Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.
    Type: Application
    Filed: January 22, 2007
    Publication date: September 30, 2010
    Applicant: NOVARTIS VACCINES AND DIAGNOSTICS INC.
    Inventors: Matthew Burger, Zhi-Jie Ni, Sabina Pecchi, Gordana Atallah, Sarah Bartulis, Kelly Frazier, Aaron Smith, Joelle Verhagen, Yanchen Zhang, Allan Wagman, Simon Ng, Keith Pfister, Daniel J. Poon, Alicia Louie, Teresa Pick, Paul Barsanti, Edwin Iwanowicz, Wendy Fantl, Thomas Hendrickson, Mark Knapp, Hanne Meritt, Charles Voliva, Marion Wiesmann, Xiahua Xin
  • Publication number: 20070034090
    Abstract: A device for providing warnings to users of household appliances having an electronic audio playback circuit (24) preprogrammed with a predetermined audio message. A power source (28) to supply power to said electronic audio playback circuit (24). A speaker or transducer (22) for converting output from said electronic audio playback circuit into audio signals. A physical displacement-activated switch (20). A housing (18) for enclosing said electronic audio playback circuit (24), speaker or transducer (22), and physical-displacement-activated switch (20). A means (26) for attaching said housing to a household appliance lid or door.
    Type: Application
    Filed: August 5, 2006
    Publication date: February 15, 2007
    Inventor: Thomas Hendrickson
  • Publication number: 20070027150
    Abstract: 2-Amino-quinazolin-5-one compounds, stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the 2-amino-quinazolin-5-one compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the 2-amino-quinazolin-5-one compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cell proliferative diseases.
    Type: Application
    Filed: April 14, 2006
    Publication date: February 1, 2007
    Inventors: Cornelia Bellamacina, Abran Costales, Brandon Doughan, Susan Fong, Zhenhai Gao, Thomas Hendrickson, Barry Levine, Xiaodong Lin, Timothy Machajewski, Christopher McBride, William Antonios-McCrea, Maureen McKenna, Kris Mendenhall, Alice Rico, Cynthia Shafer, X. Wang, Yi Xia, Yasheen Zhou
  • Publication number: 20050080121
    Abstract: Compounds of the formula: where the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picomaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also described.
    Type: Application
    Filed: July 23, 2003
    Publication date: April 14, 2005
    Inventors: Ye Hua, Hiep Luu, Fora Chan, Theodore Johnson, Siegfried Reich, Donald Skalitsky, Yi Yang, Thomas Hendrickson, Shao Chu, Brian Eastman
  • Patent number: 5852367
    Abstract: A level shifting circuit operating at low power with minimal signal delays. The circuit employs high capacitance diodes to shift signals from a first signal level to a second higher or lower signal level. The capacitance is obtained by either providing a discrete capacitor shunt across the diode or by using diode connected transistors. Diode connected transistors are biased to provide the necessary capacitance. A pair of high capacitance diode level shifters is used as a differential pair level shifter by connecting the reference resistors to a common reference potential.
    Type: Grant
    Filed: September 1, 1992
    Date of Patent: December 22, 1998
    Assignee: International Business Machines Corporation
    Inventors: David William Boerstler, Edward Baxter Eichelberger, Gary Thomas Hendrickson, Charles Barry Winn
  • Patent number: 4575816
    Abstract: A peripheral processor has an architecture wherein the function controlling information of a program is separated from portions of the sequence of execution controlling information and each are stored in the form of tables. The function controlling information takes the form of a table including a plurality of function specifying entries. The function execution sequence controlling information takes the form of a table of pointers. In this invention, function controlling entries, each having a plurality of fields for defining, modifying, and specifying the functions and related data to be executed, need not be repetitively duplicated throughout the program. Instead, the shorter pointers to the function table entries can be provided in the sequence table in the sequence in which the functions are to be executed.
    Type: Grant
    Filed: December 19, 1980
    Date of Patent: March 11, 1986
    Assignee: International Business Machines Corporation
    Inventors: Thomas A. Hendrickson, George C. Macauley, Donald L. Pierce, Robert W. Roefer, Alan B. Strickland
  • Patent number: D872565
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: January 14, 2020
    Inventor: Thomas Hendrickson